LOCAL PROVIDER DIRECTORY
Find a dentist
Search by name or specialty, then choose a city and region or enter a ZIP / postal code.
Choose a location to keep your results local.
Local Health Alerts
Medicare’s $50 GLP-1 Bridge: Who Qualifies and How to Get Treated
Medicare’s time-limited “GLP-1 Bridge” starts July 1, 2026. If you’re enrolled in an eligible Medicare Part D plan type and meet CMS’s age/BMI and health-condition criteria, your clinician can request prior authorization for certain FDA-approved GLP-1 weight-loss drugs—with a $50 copay per month…
What Medicaid “Community Engagement” Means for Coverage Starting in 2027
CMS’s June 1, 2026 interim final rule creates a Medicaid eligibility condition for certain non-pregnant adults to meet an 80-hours-per-month “community engagement” standard (or another qualifying basis). The rule also requires states to verify compliance and give enrollees a 30-calendar-day response window if…
After Wisdom Tooth Extraction: Infection Red Flags (Watch vs. Go)
Some swelling and soreness can be normal after wisdom tooth extraction—but certain changes can signal a spreading infection. Use this “watch vs. go” checklist: call your dentist/oral surgeon same day if local symptoms worsen, and go to urgent care or the ER right…
What CDC’s A(H5) Wastewater Dashboard Means for Families (and When to Call)
If your area shows an “A(H5) detected” wastewater result, it’s a community monitoring signal—not proof that anyone in your household is infected. Learn what the dashboard can and can’t tell you, and when symptoms after relevant exposure should prompt medical evaluation.
If 988 Can’t Connect: What Happens and What to Do Next
If you call or text 988 and your local crisis option can’t take your contact, the system is designed to route you to a national backup. Wait times can still vary by call/text/chat method and local demand—so if one path doesn’t connect, trying…
At-Home HPV Testing for Cervical Cancer: US Rules for Ages 30–65
New HRSA-backed U.S. cervical cancer screening guidance adds a patient-collected (at-home) option for high-risk HPV testing for average-risk adults ages 30 to 65. The preferred screening interval is every 5 years, and abnormal results may require additional follow-up tests to complete screening.
CY 2027 OPPS Proposal: 340B Drug Payments and Imaging Site-of-Care
CMS’s proposed CY 2027 Hospital OPPS/ASC rule would adjust Medicare hospital outpatient payments for certain 340B-acquired drugs, change how some outpatient imaging is paid (including rural Sole Community Hospital exemptions), and continue the phase-out of the Inpatient Only (IPO) list. CMS also issued…
FDA Updated OTC alli Label: Ask First If You’ve Had Kidney Disease
On June 10, 2026, FDA approved updates to the OTC weight-loss drug alli (orlistat 60 mg) label to highlight a rare risk of acute kidney injury and kidney stones. The label advises people who have ever had kidney disease or kidney stones to…
Mpox After Exposure: When to Get JYNNEOS and When to Seek PCR Testing
If you may have been exposed to mpox, JYNNEOS post-exposure prophylaxis works best when started within 4 days (and may still help if given up to 14 days). If you develop a new, unusual rash after a relevant exposure window, contact a clinician…
May 29, 2026 Vaccine Schedule Update: What Families Can Do Now
A May 29, 2026 executive order directs CDC and ACIP to review how childhood vaccines are organized and to update guidance using “best practices”—while aiming to preserve access to vaccines already available in the U.S. Here’s what families and schools can do today…
FDA Warns of Higher-Than-Expected Long-Term Failure Risk With Hintermann H3 Ankle Replacement
If you have a Hintermann Series H3 total ankle replacement—or are considering one—FDA says the long-term risk of device failure and possible revision surgery is higher than expected. FDA advises keeping follow-ups and contacting your health care provider promptly if specific new or…
Long COVID “Brain Fog” Trial: Goal-Oriented Rehab Helped Goals—Fatigue Didn’t
A July 1, 2026 randomized trial (CICERO) tested goal-oriented cognitive rehabilitation for long COVID “brain fog.” It improved participants’ personalized functional goal attainment at 3 months and maintained the advantage at 6 months. But the trial did not show clear improvement in fatigue/post-exertional…